Analyst Issues Sell Rating for GlaxoSmithKline Amid Market Share and Litigation Concerns

TipRanks05:28 ET · Ratings

Blenrep (Belantamab Mafodotin) in Combination Receives Breakthrough Therapy Designation in China for Treatment of Relapsed/refractory Multiple Myeloma

GSK Plc00:00 ET

GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal

Zacks Sep 12 11:00 ET

Fulcrum Crashes as GSK-partnered Lead Program Fails

Seeking AlphaSep 12 07:13 ET

Express News | Earlier Today, GSK Announced Headline Results Of A Phase 2 Trial For Its MRNA Seasonal Influenza Vaccine Program, Demonstrating A And B Strain Immune Responses Relative To Standard Of Care In Both Younger And Older Adults

BenzingaSep 12 06:38 ET

GSK's MRNA Flu Vaccine Advances to Late-Stage Clinical Development After Positive Trial Results

WSJSep 12 02:35 ET